MALAT1 and urinary bladder cancer: Zhan [41] and et.al developed a urinary exosome-derived lncRNA panel (MALAT1, PCAT-1 and SPRY4-IT1) for diagnosis and recurrence prediction of bladder cancer in a cohort consist of 368 urine samples.